← All patents

US20180171411A1

GFRalpha1 AS A BIOMARKER FOR CISPLATIN-INDUCED CHEMORESISTANCE AND METASTASIS

University of Texas System

Abstract

Certain embodiments are directed to methods and composition for detecting the level of GFRα1 in cancers and treating same.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Dae Joon Kim
Priority date
June 10, 2015
Filing date
June 10, 2016
Publication date
June 21, 2018
Language
en
Metadata fetched
August 29, 2026 00:26